vimarsana.com

Latest Breaking News On - Philipl johnson - Page 6 : vimarsana.com

Eukles Asset Management Sells 144 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the quarter. Eukles Asset Management’s holdings […]

Eukles Asset Management Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management trimmed its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the period. Eukles […]

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kendall Capital Management

Kendall Capital Management grew its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,799 shares of the specialty pharmaceutical company’s stock after buying an additional 1,795 shares during the quarter. Kendall Capital Management’s holdings in Jazz Pharmaceuticals were worth $959,000 […]

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Kendall Capital Management

Kendall Capital Management boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,799 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,795 shares […]

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Overweight Rating from Cantor Fitzgerald

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Overweight Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.